Researchers hone in on a protein's precise role in disease prevention

July 13, 2011

Building upon work initiated by University of Alabama scientists, Harvard Medical School researchers, collaborating with UA and others, took another step in cracking the code behind a protein’s precise role in the disease dystonia and, along the way, discovered a new lead for cystic fibrosis research, according to a journal article publishing today. 

The research, publishing in this week’s Nature Communications, describes the location and mechanism within a cell where a specific protein, torsinA, normally works to degrade misfolded proteins before those faulty proteins trigger problems associated with the neurological movement disorder called dystonia, said Dr. Guy Caldwell, professor of biological sciences at UA and one of the University’s three co-authors on the article.

“Last year, we started to define that torsinA is functioning within a quality control mechanism, and, in this latest paper, we hone in on the precise portion of cellular quality control that it seems to be managing,” Caldwell said.

The new findings suggest that in one area of cells, the endoplasmic reticulum – which Caldwell likens to a cell’s post office, a place where the cell’s proteins are packaged before transport to other parts of the cell – torsinA plays a key role.

In the absence of torsinA’s quality control function, the misfolding of proteins within the endoplasmic reticulum continues, leading to cell stress from protein aggregation and, eventually, to neuron malfunction, the researchers said. This neuron malfunction leads to dystonia.

In another aspect of the study, the researchers show a potentially promising relationship between torsinA activity and cystic fibrosis, a life-threatening lung disease said to be the most common disease among young Caucasians. Scientists previously knew, Caldwell said, that cystic fibrosis results from the deletion of a single amino acid within the protein called cystic fibrosis transmembrane conductance regulator, or CFTR, that must be properly folded within the endoplasmic reticulum.

The new study shows that, in both the C. elegans nematode roundworms that the Caldwell Lab uses as animal models, and in human cells, that torsinA can selectively degrade the misfolded CFTR protein, while a mutant version of torsinA is less able to do so.  

“If you are thinking about cures for cystic fibrosis, what you really want is to be able to manage the amount of CFTR protein being sent through the endoplasmic reticulum. Regulating torsinA activity has the potential to modulate that,” Caldwell said.

The Caldwell Lab was recently awarded a one-year, renewable grant from the National Institutes of Health, via the UAB Cystic Fibrosis Research Center, to continue its research.  

Likewise, Caldwell said research into dystonia has proceeded rapidly over the last decade and the latest step could prove vital in the development of therapeutic strategies.

“Until you can understand how a protein works in the cell, you can’t really develop biological assays, or tests, for the way in which it can be modified, let alone find drugs that can modify it,” he said.

Researchers from UA’s Caldwell Lab were the lead authors of a 2010 paper, also in collaboration with Harvard, publishing in Human Molecular Genetics about the role of torsinA, as well as a 2003 cover article in the same journal where torsinA’s therapeutic potential was initially linked to disorders involving management of misfolding.

About 500,000 people in North American have dystonia, a disorder that can cause repetitive, painful spasms and can affect one or many parts of the body. Patients with early-onset generalized dystonia have one good copy of the gene DYT1, and one problematic copy, in their DNA.  It’s this gene that contains the information to make torsinA.

The multi-institution effort published in Nature Communications was led by Dr. Xandra Breakefield, a professor in the department of neurology at Harvard Medical School and a geneticist at Massachusetts General Hospital. The research was done in both animal models and via skin cells obtained directly from dystonia patients.

Explore further: Severity of cystic fibrosis may be determined by presence of newly-identified modifier genes

Related Stories

Severity of cystic fibrosis may be determined by presence of newly-identified modifier genes

May 25, 2011
(Medical Xpress) -- In an age where personalized medicine is within reach, a one-size-fits-all approach just won’t cut it. A group of North American researchers have identified two “modifier” genes in the genomes ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

lengould100
not rated yet Jul 13, 2011
From Meriam-Webster:

"The few commentators who have noticed hone in consider it to be a mistake for home in. It may have arisen from home in by the weakening of the \m\ sound to \n\ or may perhaps simply be due to the influence of hone. Though it seems to have established itself in American English (and mention in a British usage book suggests it is used in British English too), your use of it especially in writing is likely to be called a mistake. Home in or in figurative use zero in does nicely."

It is like applying a grindstone to the ear.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.